Stay ahead of the game with the latest developments at EnvoyHealth and throughout the industry.

Diplomat Promotes Executive Jennifer Cretu

Apr 13, 2017

FLINT, Mich. – April 13, 2017 – The nation’s largest independent specialty pharmacy has promoted Jennifer Cretu to senior vice president of pharma services and marketing.

Diplomat Pharmacy, Inc. (NYSE: DPLO), has promoted Jennifer Cretu in a strategic move to support its subsidiary Envoy Health Management, LLC.

Cretu will serve as senior vice president of pharma services and marketing.

To learn more about  EnvoyHealth, visit

Cretu will begin managing pharma services for EnvoyHealth, which offers comprehensive program solutions to help manufacturers get their medications to market and in the hands of the patients who need them. She will continue to oversee Diplomat’s marketing, public relations, and corporate communications.

EnvoyHealth meets the challenges of patient access through cost-effective personal care and comprehensive management, tailoring its scalable approach to support each partner’s specific needs and timelines. The company uses fee-for-service offerings to build program solutions for manufacturers, hospitals, payors, providers, and more.

“We are excited to announce the expansion of Jennifer’s role,” said Phil Hagerman, Diplomat CEO and chairman. “With a proven track record of developing innovative marketing strategies to drive Diplomat’s business objectives, she is the ideal leader as we grow and expand our EnvoyHealth services arm. Her new role represents a significant step for the development of our company. She joins a dynamic team that is providing complete solutions that meet the specialized needs of our customers.”

Specializing in strategy and execution, Jennifer performs in roles that evolve as the company itself advances. Previously, she served as executive director of IT and later as vice president of IT and marketing, managing operations and strategic planning. In her prior roles, she worked to ensure the departments aligned and drove the organization’s business objectives.

Before joining Diplomat in December 2012, Jennifer served at as senior business manager of their pharmacy and vision division. There, she was accountable for the end-to-end business, managing products and services; customer experience; and cross-functional partnerships. Before this role, she served as business strategy manager in Hewlett-Packard’s Imaging & Printing Group. With HP, she managed the growth of the worldwide OEM business and was charged with developing business models and program portfolios, as well as directing contract negotiations.

Cretu received her primary degree from University of California–San Diego and her Master of Business Administration from the Paul Merage School of Business at University of California Irvine.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management’s good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat’s filings with the Securities and Exchange Commission, including “Risk Factors” in Diplomat’s Annual Report on Form 10-K for the year ended Dec. 31, 2016, and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise.

About Diplomat

Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit


Kali Lucas, Public Relations Specialist
810.768.9580 |

Contact Us

Are you ready to stand out? Let's talk.

Industry expertise. Collaborative partnership. Iterative solutions. Let’s extend your reach and build your market presence.

This form is for business inquiries only. If you have a medical question or concern, please contact your healthcare provider.